Healthcare

CONNECTA Therapeutics to Advance CTH120 into Phase II Pediatric Development for Fragile X Syndrome with EIC Accelerator Support

BARCELONA, Spain, Sept. 9, 2025, 03:30 GMT-04

CONNECTA-Therapeutics

Read full article →

iOnctura Expands Roginolisib Trials to the US, Advancing Multi-Indication Strategy in Oncology

GENEVA, AMSTERDAM and CAMBRIDGE, Mass., Sept. 9, 2025, 03:00 GMT-04

iOnctura

Read full article →

Elevating Healthcare Innovation: ICP DAS-BMP Brings Advanced TPU Portfolio at Medtec China 2025

HSINCHU, Sept. 9, 2025, 21:45 GMT-04

ICP-DAS-Medtec-China

Read full article →

Asthma Market to Show Paltry Growth at a CAGR of 1.95% During the Forecast Period (2025-2034) | DelveInsight

LAS VEGAS, Sept. 8, 2025, 17:31 GMT-04

DelveInsight-Business

Read full article →

Wearable Healthcare Devices Market worth US$75.98 billion by 2030 with 10.9% CAGR | MarketsandMarkets™

DELRAY BEACH, Fla., Sept. 8, 2025, 10:45 GMT-04

MARKETSANDMARKETS

Read full article →

Liquid Biopsy Market to Reach USD 30.65 Billion by 2035, with CAGR 9.41% Driven by Rising Cancer Burden and Demand for Non-Invasive Diagnostics - Vantage Market Research

NEW YORK, Sept. 8, 2025, 10:33 GMT-04

VANTAGE-MARKET

Read full article →

Disposable Medical Device Market worth US$144.85 billion by 2030 with 4.9% CAGR | MarketsandMarkets™

DELRAY BEACH, Fla., Sept. 8, 2025, 10:01 GMT-04

MARKETSANDMARKETS

Read full article →

Breakthrough Therapy Designations Surge as $50B Cancer Drug Partnerships Reshape Market

VANCOUVER, BC, Sept. 8, 2025, 09:30 GMT-04

USA-News-Group

Read full article →

Sirtex Receives Expanded CE Mark Approval for SIR-Spheres® Y-90 Resin Microspheres

WOBURN, Mass., Sept. 8, 2025, 09:00 GMT-04

Sirtex-Medical-Inc-UK

Read full article →

Centrifuge Market worth $0.63 billion by 2030 - Exclusive Report by MarketsandMarkets™

DELRAY BEACH, Fla., Sept. 8, 2025, 06:55 GMT-04

MARKETSANDMARKETS

Read full article →

Transcatheter Aortic Valve Replacement (TAVR) Market to Reach USD 14.06 Billion by 2035, with CAGR 6.9% Driven by Aging and Minimally Invasive Heart Procedures - Vantage Market Research

NEW YORK, Sept. 8, 2025, 06:35 GMT-04

VANTAGEMARKETRESEARCH

Read full article →

FDA Accepts Letter of Intent to Qualify LSM by VCTE (FibroScan®) as First Non-Invasive Surrogate Endpoint in MASH Clinical Trials

WESTBOROUGH, Mass., Sept. 8, 2025, 06:00 GMT-04

Echosens-MASHClinical

Read full article →

Servier acquires potential treatment for Fragile X syndrome, the most common genetic cause of autism spectrum disorder

SURESNES, France, Sept. 8, 2025, 03:41 GMT-04

Servier-Acq-KER-0193

Read full article →

Alkermes Presents Detailed Positive Results from Vibrance-1 Phase 2 Study of Alixorexton in Patients with Narcolepsy Type 1 at World Sleep Congress 2025

DUBLIN, Sept. 8, 2025, 03:15 GMT-04

Alkermes-Study

Read full article →

Newronika Appoints Keith Carlton as Executive Chairman to Reinforce Strategic Leadership

MILAN, Sept. 8, 2025, 02:00 GMT-04

Newronika-Appt

Read full article →

Digital Health Market worth US$573.5 billion by 2030 with 23.6% CAGR | MarketsandMarkets™

DELRAY BEACH, Fla., Sept. 6, 2025, 10:45 GMT-04

MarketsandMarkets

Read full article →

Catheters Market worth US$45.99 billion by 2030 with 8.5% CAGR | MarketsandMarkets™.

DELRAY BEACH, Fla., Sept. 5, 2025, 10:45 GMT-04

MARKETSANDMARKETS

Read full article →

Glenmark Initiates a Multi-Country Phase 3 Clinical Trial for Envafolimab in Resectable Stage III Non-Small Cell Lung Cancer

MUMBAI, India, Sept. 5, 2025, 10:00 GMT-04

GLENMARK-PHARMA

Read full article →

Huadong Medicine Announces Positive Preliminary Results from a Phase Ⅰ study of HDM2005, a ROR1-Targeting ADC

HANGZHOU, China, Sept. 5, 2025, 09:25 GMT-04

HuaDongMedicine-study

Read full article →

'CART BP pro' Opens a New Paradigm in Blood Pressure Management, Maintaining Accuracy Across Arm Positions

SEOUL, South Korea, Sept. 5, 2025, 09:01 GMT-04

Sky-Labs

Read full article →